A B S T R A C T The microsomal enzyme uridine diphosphate (UDP) glucuronate glucuronyltransferase (E.C. 2.4.1.17) catalyzes formation of bilirubin monoglucuronide from bilirubin and UDPglucuronic acid. Bilirubin glucuronoside glucuronosyltransferase (E.C. 2.4.1.95), an enzyme concentrated in plasma membrane-enriched fractions of rat liver, converts bilirubin monoglucuronide to bilirubin diglucuronide. Bilirubin glucuronoside glucuronosyltransferase activity was studied in homogenates of liver biopsy specimens obtained from patients with the Crigler-Najjar syndrome (Type I) and in subcellular liver fractions of rats homozygous for UDPglucuronate glucuronyltransferase deficiency (Gunn strain). In patients with the Crigler-Najiar syndrome (Type I) and in Gunn rats, hepatic UDPglucuronate glucuronyltransferase activity was not measurable; however, bilirubin glucuronoside glucuronosyltransferase activity was similar to that in normal controls. The subcellular distribution of bilirubin glucuronoside glucuronosyltransferase activity in Gunn rat liver was similar to the distribution observed in normal Wistar rat liver.
When bilirubin monoglucuronide was infused intravenously into Gunn rats, 29±+5% of the conjugated bilirubin excreted in bile was bilirubin diglucuronide. After transplantation ofnormal Wistar rat kidney, which contained UDPglucuronate glucuronyltransferase activity, in Gunn rats, the serum bilirubin concentration decreased by 80% in 4 days. The major route of bilirubin removal was biliary excretion of conjugated bilirubin, approximately 70% of which was bilirubin INTRODUCTION Bilirubin diglucuronide is the major pigment in human and rat bile (1) . Uridine diphosphate (UDP)glucuronate glucuronyltransferase (E .C.2.4. 1.17)1 is a microsomal enzyme which catalyzes formation of bilirubin monoglucuronide from unconjugated bilirubin and UDP glucuronic acid. Bilirubin diglucuronide formation requires a second enzyme, bilirubin glucuronoside glucuronosyltransferase (E.C.2.4.1.95), which is concentrated in a plasma membrane-enriched fraction of rat liver, and catalyzes transglucuronidation of 2 mol of bilirubin monoglucuronide to 1 mol of bilirubin diglucuronide and 1 mol of unconjugated bilirubin (2) .
Patients with the Crigler-Najjar syndrome (Type I) and homozygous Gunn rats lack hepatic UDPglucuronate glucuronyltransferase activity with bilirubin as a substrate. Their bile lacks bilirubin glucuronides and contains only small amounts of unconjugated bilirubin (3) (4) (5) . The present study was performed to determine whether patients with the Crigler-Najjar syndrome (Type I) and Gunn rats convert bilirubin monoglucuronide to diglucuronide in vitro and in vivo. (2) and UDPglucuronate glucuronyltransferase activity were then determined (6) .
METHODS
Preparation of subcellular fractions. Male homozygous Gunn rats and normal Wistar rats were fasted for 18 h and given water ad libitum before decapitation. The livers were perfused, homogenized and fractionated according to Touster et al. (7) . Nuclear (N), mitochondrial and lysosomal (M + L), microsomal, and cytosol fractions were prepared (7). The nuclear and microsomal fractions were subfractionated on discontinuous sucrose gradients (7) . The fraction at the 7.5-37.2% interface (N2), the 37.2% sucrose fraction, including the 37.2-47% interface (N3), and the 47% sucrose fraction including the pellet (N4) were collected. From the microsomal fraction, P2 fraction was collected from the 7.5-34% interface, P3 was the part of the 34% sucrose fraction above the thick band at the 34-49% interface, and P4 contained this band and the 49% sucrose fraction.
Conversion of bilirubin monoglucuronide to diglucuronide (bilirubin glucuronoside glucuronosyltransferase) and activities of marker enzymes were measured in fractions stored at 4°C for not longer than 3 days. This treatment had no effect on enzyme activity when studied in liver fractions from Wistar rats.
Enzyme assays. For assay of bilirubin glucuronoside glucuronosyltransferase activity, bilirubin monoglucuronide was prepared biosynthetically (2) . Liver homogenate or subfractions containing 50 A.l enzyme, 1 ,tmol glucaro-1,4 lactone, and 20 ,umol sodium phosphate in a final volume of 0.2 ml, at pH 6.4 were incubated at 25°C for 60 min. Glucaro-1,4 lactone was included to inhibit ,3-glucuronidase present in homogenates or cell fractions. The reaction was started by adding bilirubin monoglucuronide, 28-34 ,umol in 50 pI Tris HCI buffer 0.1 M, pH 7.8. Blanks contained enzyme preparations inactivated by placing in boiling water for 10 min (2). After incubation for 3 min at 37°C, the tubes were transfered to ice and 2 ml ethyl anthranilate diazo reagent was added (8) . After 30 min at 25°C, the reaction was terminated by adding 1 ml 20% ascorbic acid; azopigments were extracted in 0.5 ml methylpropyl ketone/butyl acetate (17/3, vol/vol), and 0.2-ml aliquots were applied to precoated silica gel plates. The plates were developed in chloroform/methanol/water (65/25/3, vol/vol/vol). Two spots appear which contain unconjugated (a0) or conjugated (8) azopigments. The spots were scraped off, and extracted in 1 ml methanol. Azopigments were quantitated spectrophotometrically at 530 nm (maximal absorbance). Unconjugated azopigment (ao) is derived from bilirubin monoglucuronide only, whereas glucuronidated azopigments are derived from the conjugated half of bilirubin monoglucuronide and from bilirubin diglucuronide. The conversion rate of bilirubin monoglucuronide to bilirubin diglucuronide was calculated from (8 -ao) reaction minus (8 -a0) blank, utilizing E330 for bilirubin, 44.4 x 103/M per cm (8) . When tested on rat liver, the assay is linear for the duration of incubation and in the range of amount of tissue homogenate or subcellular fractions used.
Bilirubin monoglucuronide formation (UDPglucuronate glucuronyltransferase activity) was determined as previously described (9) . Glucose-6-phosphate activity was determined according to Swanson (10) . 5'nucleotidase activity with adenosine monophosphoric acid as substrate, and phosphodiesterase-I activity with p-nitrophenyl 5'thymidilate as substrate were assayed as described by Touster et al. (7) . Protein was determined by the method of Lowry et al. (11) with bovine serum albumin as standard. Serum total and conjugated bilirubin were determined by the method of Malloy and Evelyn (12) , and serum creatinine was determined as described by Owen et al. (13) .
Studies in vivo. Under light ether anesthesia, five male Gunn rats were provided with polyethylene canalae (Intramedic PE 10) in their jugular veins and bile ducts. During a 1-h control period, the rats received 5% dextrose 0.33% sodium chloride intravenously at 0.3 ml/min with a pump. Only rats which produced a minimum of 0.2 ml bile per 10-min period were used. Bilirubin monoglucuronide nmol in Tris HCI buffer 0.1 M, pH 8), 4.8 ml, was infused for 16 min. Bile was collected for 3 20-min intervals during the control period, and for 12 20-min periods after infusion. Total conjugated bilirubin was determined and diazo pigments were analyzed by thin layer chromatography for quantitation of bilirubin monoglucuronide and diglucuronide (14) .
Two female Gunn rats underwent bilateral nephrectomy under light ether anesthesia. Normal female Wistar rats served as kidney donors. The donor kidney was removed immediately before transplantation and cooled with ice-cold 0.9% NaCl during the procedure. With vascular occlusion clamps, the renal vein and artery of the donor organ were anastomosed with the aorta and vena cava, respectively, of the recipient animal. The ureters were connected with silastic tubing. Operated rats were kept in metabolic cages in a dark room, and were given rat chow and water ad libitum. Urine was collected in 12-h specimens for 4 days. Serum concentrations of bilirubin, conjugated bilirubin, and creatinine were determined daily starting 2 days before surgery. 96 h after surgery, the urinary bladder was catheterized through the urethra with a silastic catheter and the bile duct was cannulated with a polyethylene (PE 10) tubing. Bile and urine were collected for 3 h; the animal was decapitated, and the transplanted kidney was removed. The renal cortex was removed with a razor blade, homogenized in 3 ml/g tissue of Tris HCI buffer, pH 8, 0.005 M with sucrose 0.25 M, and UDPglucuronyl transferase activity was determined (8) . Bilirubin monoglucuronide and diglucuronide concentrations in bile and urine were determined as described (2, 14) . 192 Chowdhury, Jansen, Fischberg, Daniller, and Arias
RESULTS

Studies in vitro
The distributions of bilirubin glucuronoside glucuronosyltransferase, UDPglucuronate glucuronyltransferase, and other marker enzymes were measured in subcellular fractions of Gunn rat liver. The distributions were compared to those in normal Wistar rat liver fractions as previously described (2) .
None of the Gunn rats had detectable glucuronyl transferase activity in any liver fraction (Table I) . About 80% of glucose-6-phosphatase activity was recovered in the microsomal fraction; after subfractionation the highest specific activity for this enzyme occurred in fraction P4 (Table I ).
The distribution of bilirubin glucuronoside glucuronosyl transferase was similar to the distribution of 5'nucleotidase and phosphodiesterase I activities. These enzymes have a bimodal distribution with highest recovery in the nuclear and microsomal fractions (Table I ). The highest specific activities for conversion of bilirubin monoglucuronide to diglucuronide, 5'nucleotidase, and phosphodiesterase I occurred in fractions N2 and P2 (Table I) .
Liver from normal human controls and patients with the Crigler-Najjar syndrome. Livers from the two patients with the Crigler-Najjar syndrome (Type I) had no detectable glucuronyltransferase activity. Bilirubin glucuronoside glucuronosyltransferase activities in control livers and in livers from patients with the Crigler-NajJar syndrome, type I (two cases) 0, 0 0, 0 301, 298 1.50, 1.51 Results are expressed as mean±SE or as individual values.
Crigler-Najiar syndrome (Type I) were not significantly different (Table II) .
Studies in vivo Bilirubin monoglucuronide infusion. After intravenous infusion of 475±25 nmol bilirubin monoglucuronide, which contained only 0-2 nmol bilirubin diglucuronide, 316+20 nmol conjugated bilirubin was recovered in bile in 4 h. Thin layer chromatography of the azo pigments from control Gunn rat bile revealed no glucuronide band (8), a faint a0, and an unidentified band immediately behind the ao band. For calculation of bilirubin diglucuronide and monoglucuronide (Table III) in Gunn rat bile following infusion of bilirubin monoglucuronide, it was assumed that the contribution to the ca0 band by unconjugated bilirubin in bile remained constant. Of conjugated bilirubin excreted in bile, 29+5% (SE) was bilirubin diglucuronide (Table III) .
Renal transplantation. Serum total bilirubin and creatinine concentrations before and after renal transplantation in Gunn rats are shown in Fig. 1 . Serum creatinine concentration remained within normal limits and serum bilirubin concentrations decreased by 80%. Because of lability of conjugated bilirubin, urine collected in metabolic cages could not be analyzed quantitatively for its pigments; however, analysis obtained on termination of the experiment revealed that urinary excretion of bilirubin was much less than was biliary excretion of bilirubin (Table IV) . UDPglucuronyltransferase activity in cortical homogenates from transplanted kidneys was 310 and 375 nmol/20 min per g kidney tissue (wet weight). Renal cortical homogenates from six normal Wistar rats had glucuronyltransferase activity of 210+25 nmol/20 min per g wet weight. No glucuronyltransferase activity was detected in homogenates of renal cortex from four control Gunn rats. Bilirubin glucuronoside glucuronosyltransferase activity in renal cortical homogenates in six normal and four Gunn rats was 202±28 nmol/g per min and 216±32 nmol/g per min, respectively.
DISCUSSION
Conversion of bilirubin to a more polar conjugate is essential for its biliary excretion (15) . Recent studies (2) ofthe bilirubin conjugating system in rat and human liver reveal that two distinct enzymes are required for formation of bilirubin diglucuronide. UDPglucuronate glucuronyltransferase the microsomal enzyme required for conversion of bilirubin to bilirubin monoglucuronide, is present in the renal cortex (16) , small intestinal mucosa (17) , and liver. Bilirubin monoglucuronide transglucuronidation activity is present in rat liver and renal cortex (18), but not in erythrocyte Results are expressed as mean+SE. The present study confirms the presence of glucuronyltransferase activity in normal rat kidney (19) . Glucuronyltransferase activity in the cortex ofthe trans2Chowdhury, J. R. Unpublished observations. 3 Chowdhury, J. R. Unpublished observations. planted kidney was about 60% higher than that in the renal cortex of normal Wistar rats. Similar findings were observed by Foliot et al. (19) . The mechanism for this effect is unknown. After renal transplantation from a normal rat into a Gunn rat, conjugated bilirubin was excreted predominantly in bile and, to a lesser extent, in urine. The transplanted normal rat kidney served as an internal source of glucuronyltransferase. The conjugate excreted in bile was predominantly bilirubin diglucuronide. Since the kidney from normal and Gunn rats has bilirubin glucuronoside glucuronosyltransferase activity, it is not possible to determine from these experiments whether the diglucuronide excreted in bile is produced in the transplanted kidney or in the liver of the Gunn rat. Correction of the metabolic defect in Gunn rats by transplantation of normal rat kidney suggests that renal transplantation may benefit patients with the Crigler-Najjar syndrome (Type I) who usually die of kernicterus in infancy or early childhood (5) . Further studies are required to characterize UDPglucuronyltransferase in human kidney before this can be attempted.
